Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Keysight Technologies	KEYS	30. oct 2024	151.98	-2.12
Kezar Life Sciences	KZR	30. oct 2024	8.19	+991.42
KFA Global Carbon ETF	KRBN	30. oct 2024	32.02	-0.59
Kforce	KFRC	30. oct 2024	58.40	+2.35
Kidpik	PIK	30. oct 2024	2.36	+0.85
Kilroy Realty	KRC	30. oct 2024	40.77	-1.24
Kimball Electronics	KE	30. oct 2024	18.19	-0.38
Kimbell Royalty Partners LP Units	KRP	30. oct 2024	16.04	+0.31
Kimberly-Clark	KMB	30. oct 2024	134.41	-0.07
Kimco Realty	KIM	30. oct 2024	24.02	+1.48
Kimco Realty L Pref	KIM-L	30. oct 2024	22.73	-0.18
Kimco Realty M Pref	KIM-M	30. oct 2024	23.28	+0.74
Kimco Realty Pref ADR	KIM-N	30. oct 2024	60.76	+0.66
Kinder Morgan	KMI	30. oct 2024	24.84	+0.85
Kindercare Learning Companies	KLC	30. oct 2024	29.41	0.00
Kindly MD	KDLY	30. oct 2024	1.03	+3.00
Kineta	KA	30. oct 2024	0.83	0.00
Kinetik A	KNTK	30. oct 2024	49.03	+0.31
Kingsoft Cloud ADR	KC	30. oct 2024	2.86	-2.39
Kingstone Companies	KINS	30. oct 2024	10.33	+3.40
Kingsway Financial Services	KFS	30. oct 2024	9.18	-0.54
Kiniksa Pharmaceuticals	KNSA	30. oct 2024	23.01	-1.10
Kinross Gold	KGC	30. oct 2024	10.48	-2.06
Kinsale Capital Group	KNSL	30. oct 2024	429.82	-0.93
Kiora Pharmaceuticals	KPRX	30. oct 2024	3.70	-3.90
Kirby	KEX	30. oct 2024	115.59	-6.06
Kirklands	KIRK	30. oct 2024	1.64	-6.29
Kite Realty Group Trust	KRG	30. oct 2024	26.04	+1.17
KKR & Co	KKR	30. oct 2024	140.18	+0.61
KKR Income Opportunities Fund	KIO	30. oct 2024	14.02	+0.50

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.